載入...
Botulinum Toxin in Movement Disorders: An Update
Since its initial approval in 1989 by the US Food and Drug Administration for the treatment of blepharospasm and other facial spasms, botulinum toxin (BoNT) has evolved into a therapeutic modality for a variety of neurological and non-neurological disorders. With respect to neurologic movement disor...
Na minha lista:
| 發表在: | Toxins (Basel) |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7827923/ https://ncbi.nlm.nih.gov/pubmed/33430071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins13010042 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|